Cargando…

Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors

BACKGROUND: Surgery is an important treatment option for desmoid tumor (DT) patients, but how to decrease and predict the high recurrence rate remains a major challenge. METHODS: Desmoid tumor patients diagnosed and treated at Tianjin Cancer Institute & Hospital were included, and a web-based no...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haotian, Huang, Kai, Li, Tao, Yang, Tielong, Liao, Zhichao, Zhang, Chao, Xiang, Lijie, Chen, Yong, Yang, Jilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947817/
https://www.ncbi.nlm.nih.gov/pubmed/33718222
http://dx.doi.org/10.3389/fonc.2021.634648
_version_ 1783663307004051456
author Liu, Haotian
Huang, Kai
Li, Tao
Yang, Tielong
Liao, Zhichao
Zhang, Chao
Xiang, Lijie
Chen, Yong
Yang, Jilong
author_facet Liu, Haotian
Huang, Kai
Li, Tao
Yang, Tielong
Liao, Zhichao
Zhang, Chao
Xiang, Lijie
Chen, Yong
Yang, Jilong
author_sort Liu, Haotian
collection PubMed
description BACKGROUND: Surgery is an important treatment option for desmoid tumor (DT) patients, but how to decrease and predict the high recurrence rate remains a major challenge. METHODS: Desmoid tumor patients diagnosed and treated at Tianjin Cancer Institute & Hospital were included, and a web-based nomogram was constructed by screening the recurrence-related risk factors using Cox regression analysis. External validation was conducted with data from the Fudan University Shanghai Cancer Center. RESULTS: A total of 385 patients were identified. Finally, after excluding patients without surgery, patients who were lost to follow-up, and patients without complete resection, a total of 267 patients were included in the nomogram construction. Among these patients, 53 experienced recurrence, with a recurrence rate of 19.85%. The 3-year and 5-year recurrence-free survival (RFS) rates were 82.5% and 78%, respectively. Age, tumor diameter, admission status, location, and tumor number were correlated with recurrence in univariate Cox analysis. In multivariate Cox analysis, only age, tumor diameter and tumor number were independent risk factors for recurrence and were then used to construct a web-based nomogram to predict recurrence. The concordance index (C-index) of the nomogram was 0.718, and the areas under the curves (AUCs) of the 3-year and 5-year receiver operating characteristic (ROC) curves were 0.751 and 0.761, respectively. In the external validation set, the C-index was 0.706, and the AUCs of the 3-year and 5-year ROC curves are 0.788 and 0.794, respectively. CONCLUSIONS: Age, tumor diameter, and tumor number were independent predictors of recurrence for DTs, and a web-based nomogram containing these three predictors could accurately predict RFS (https://stepforward.shinyapps.io/Desmoidtumor/).
format Online
Article
Text
id pubmed-7947817
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79478172021-03-12 Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors Liu, Haotian Huang, Kai Li, Tao Yang, Tielong Liao, Zhichao Zhang, Chao Xiang, Lijie Chen, Yong Yang, Jilong Front Oncol Oncology BACKGROUND: Surgery is an important treatment option for desmoid tumor (DT) patients, but how to decrease and predict the high recurrence rate remains a major challenge. METHODS: Desmoid tumor patients diagnosed and treated at Tianjin Cancer Institute & Hospital were included, and a web-based nomogram was constructed by screening the recurrence-related risk factors using Cox regression analysis. External validation was conducted with data from the Fudan University Shanghai Cancer Center. RESULTS: A total of 385 patients were identified. Finally, after excluding patients without surgery, patients who were lost to follow-up, and patients without complete resection, a total of 267 patients were included in the nomogram construction. Among these patients, 53 experienced recurrence, with a recurrence rate of 19.85%. The 3-year and 5-year recurrence-free survival (RFS) rates were 82.5% and 78%, respectively. Age, tumor diameter, admission status, location, and tumor number were correlated with recurrence in univariate Cox analysis. In multivariate Cox analysis, only age, tumor diameter and tumor number were independent risk factors for recurrence and were then used to construct a web-based nomogram to predict recurrence. The concordance index (C-index) of the nomogram was 0.718, and the areas under the curves (AUCs) of the 3-year and 5-year receiver operating characteristic (ROC) curves were 0.751 and 0.761, respectively. In the external validation set, the C-index was 0.706, and the AUCs of the 3-year and 5-year ROC curves are 0.788 and 0.794, respectively. CONCLUSIONS: Age, tumor diameter, and tumor number were independent predictors of recurrence for DTs, and a web-based nomogram containing these three predictors could accurately predict RFS (https://stepforward.shinyapps.io/Desmoidtumor/). Frontiers Media S.A. 2021-02-25 /pmc/articles/PMC7947817/ /pubmed/33718222 http://dx.doi.org/10.3389/fonc.2021.634648 Text en Copyright © 2021 Liu, Huang, Li, Yang, Liao, Zhang, Xiang, Chen and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Haotian
Huang, Kai
Li, Tao
Yang, Tielong
Liao, Zhichao
Zhang, Chao
Xiang, Lijie
Chen, Yong
Yang, Jilong
Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
title Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
title_full Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
title_fullStr Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
title_full_unstemmed Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
title_short Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
title_sort development, validation, and visualization of a web-based nomogram for predicting the recurrence-free survival rate of patients with desmoid tumors
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947817/
https://www.ncbi.nlm.nih.gov/pubmed/33718222
http://dx.doi.org/10.3389/fonc.2021.634648
work_keys_str_mv AT liuhaotian developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors
AT huangkai developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors
AT litao developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors
AT yangtielong developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors
AT liaozhichao developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors
AT zhangchao developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors
AT xianglijie developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors
AT chenyong developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors
AT yangjilong developmentvalidationandvisualizationofawebbasednomogramforpredictingtherecurrencefreesurvivalrateofpatientswithdesmoidtumors